Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rita Lombardi
Observed name:
Lombardi, Rita
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0000-0002-3098-9134
Observed ORCID:
0000-0002-3098-9134
OpenAlex ID:
A5032374733
Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models
2022
·
Stefania Cocco
, Alessandra Leone
, et al.
·
Journal of Translational Medicine
·
138
PDF
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
2019
·
Chiara Ciardiello
, Alessandra Leone
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
132
PDF
Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
2018
·
Federica Iannelli
, Rita Lombardi
, et al.
·
Recent Patents on Anti-Cancer Drug Discovery
·
119
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
2020
·
Federica Iannelli
, Maria Serena Roca
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
66
PDF
Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid
2015
·
Valentina Bizzarro
, Raffaella Belvedere
, et al.
·
Oncotarget
·
64
PDF
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
2020
·
Federica Iannelli
, Andrea Ilaria Zotti
, et al.
·
Frontiers in Cell and Developmental Biology
·
36
Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype
2014
·
Maria Rita Milone
, Biagio Pucci
, et al.
·
Oncotarget
·
27
PDF
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer
2020
·
Rita Lombardi
, Maura Sonego
, et al.
·
Molecular Oncology
·
20
PDF
Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
2022
·
Laura Grumetti
, Rita Lombardi
, et al.
·
Cancers
·
19
PDF
Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype
2016
·
Maria Rita Milone
, Biagio Pucci
, et al.
·
Molecular Oncology
·
19
PDF
Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer
2025
·
Maria Serena Roca
, Rita Lombardi
, et al.
·
Cell Death and Disease
·
15
PDF
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer
2022
·
Susan Costantini
, Andrea Polo
, et al.
·
Cancers
·
15
PDF
Novel pathways involved in cisplatin resistance identified by a proteomics approach in non‐small‐cell lung cancer cells
2018
·
Maria Rita Milone
, Rita Lombardi
, et al.
·
Journal of Cellular Physiology
·
13
Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers
2024
·
Emeshaw Damtew Zebene
, Rita Lombardi
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling
2024
·
Federica Iannelli
, Rita Lombardi
, et al.
·
Cancer Cell International
·
10
PDF
Serum-Based Proteomic Approach to Identify Clinical Biomarkers of Radiation Exposure
2025
·
Emeshaw Damtew Zebene
, Biagio Pucci
, et al.
·
Cancers
·
2
Abstract 2877: Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting cancer stem cells compartment via YAP-pathway modulation
2018
·
Federica Iannelli
, Maria Serena Roca
, et al.
·
Cancer Research
·
2
Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancer
2026
·
Rita Lombardi
, Laura Addi
, et al.
·
Cell Death and Disease
·
1
PDF
Abstract 1700: Valproic acid potentiates the efficacy of anti-EGFR monoclonal antibodies in sensitive and resistant RAS/BRAF wild type colorectal cancer models
2025
·
Roberta Affatato
, Elena Di Gennaro
, et al.
·
Cancer Research
·
1
Abstract 4745: Repurposing of valproic acid and simvastatin combination as anticancer agents in prostate cancer: synergistic interaction with docetaxel and suppression of docetaxel resistance
2016
·
Federica Iannelli
, Rita Lombardi
, et al.
·
Cancer Research
·
1
Inhibition of the Adenosine pathway activates the immune response against Mesothelioma
2026
·
Caterina Costa
, Steven G. Gray
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Proteomic identification of HSP90 Co-chaperones as therapeutic targets for drug repurposing in platinum resistant cancers
2026
·
Sofia Piscitelli
, Rita Lombardi
, et al.
PDF
Abstract 7097: Integrated proteomics and metabolomics reveals new insight into the synergistic interaction of valproic acid plus simvastatin in prostate cancer xenograft model associated with down-modulation of YAP and TAZ signaling
2024
·
Federica Iannelli
, Rita Lombardi
, et al.
·
Cancer Research
Abstract 3232: Combined inhibition of mTOR and HSP90 potentiates cisplatin antitumor effect and reverts cisplatin resistance in vitro and in vivo models of epithelial ovarian cancer by modulating HSF1-dependent transactivation
2022
·
Rita Lombardi
, Laura Addi
, et al.
·
Cancer Research
Author response for "HSP90 identified by a proteomic approach as druggable target to reverse platinum‐resistance in ovarian cancer"
2020
·
Rita Lombardi
, Maura Sonego
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
43
Citation count:
711
H-index:
13
I10-index:
15
Year
Topic
Type